$CBDY
Target Group Inc.

2023 Q4 Form 10-Q Financial Statement

#000141057823002246 Filed on November 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $1.915M $1.046M
YoY Change
Cost Of Revenue $1.242M $454.2K
YoY Change
Gross Profit $673.3K $592.0K
YoY Change
Gross Profit Margin 35.16% 56.58%
Selling, General & Admin $367.7K $380.0K
YoY Change 8.05% 11.55%
% of Gross Profit 54.61% 64.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $131.6K $237.8K
YoY Change -37.87% 7.89%
% of Gross Profit 19.55% 40.17%
Operating Expenses $596.7K $648.5K
YoY Change 82.84% 132.84%
Operating Profit $76.66K -$56.50K
YoY Change
Interest Expense -$397.3K $337.7K
YoY Change 62.12% 25.48%
% of Operating Profit -518.29%
Other Income/Expense, Net -$7.870K -$300.3K
YoY Change -112.23% 490.11%
Pretax Income -$185.0K -$356.8K
YoY Change -95.28% 24.69%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$185.0K -$356.8K
YoY Change -95.28% 24.69%
Net Earnings / Revenue -9.66% -34.1%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 617.0M 617.0M
Diluted Shares Outstanding 617.0M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $736.3K $450.0K
YoY Change 228.95% 127.61%
Cash & Equivalents $745.0K $453.9K
Short-Term Investments
Other Short-Term Assets $55.27K $50.00K
YoY Change -91.88% -91.08%
Inventory $1.216M $1.893M
Prepaid Expenses $42.72K $41.79K
Receivables $1.032M $128.2K
Other Receivables $3.780K $70.00K
Total Short-Term Assets $3.094M $2.585M
YoY Change 240.03% 199.59%
LONG-TERM ASSETS
Property, Plant & Equipment $5.430M $5.428M
YoY Change -2.23% -4.74%
Goodwill $269.5K $263.6K
YoY Change 2.41% -92.26%
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change -100.0% -100.0%
Other Assets
YoY Change
Total Long-Term Assets $5.747M $5.742M
YoY Change -13.66% -41.05%
TOTAL ASSETS
Total Short-Term Assets $3.094M $2.585M
Total Long-Term Assets $5.747M $5.742M
Total Assets $8.841M $8.327M
YoY Change 16.86% -21.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $372.0K $530.0K
YoY Change -92.73% -88.09%
Accrued Expenses $2.750M $2.270M
YoY Change 53.48% 54.88%
Deferred Revenue
YoY Change
Short-Term Debt $990.00 $0.00
YoY Change 0.0% -100.0%
Long-Term Debt Due $7.880M $2.126M
YoY Change 353.69% 15.59%
Total Short-Term Liabilities $14.59M $8.411M
YoY Change 110.6% 31.83%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $5.583M
YoY Change -100.0% -3.17%
Other Long-Term Liabilities $1.224M $1.230M
YoY Change -7.26% -7.64%
Total Long-Term Liabilities $1.224M $6.771M
YoY Change -82.99% -3.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.59M $8.411M
Total Long-Term Liabilities $1.224M $6.771M
Total Liabilities $15.81M $15.18M
YoY Change 11.95% 13.42%
SHAREHOLDERS EQUITY
Retained Earnings -$31.11M -$30.92M
YoY Change 1.05% 15.12%
Common Stock $61.70K $61.70K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.973M -$6.855M
YoY Change
Total Liabilities & Shareholders Equity $8.841M $8.327M
YoY Change 16.86% -21.46%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$185.0K -$356.8K
YoY Change -95.28% 24.69%
Depreciation, Depletion And Amortization $131.6K $237.8K
YoY Change -37.87% 7.89%
Cash From Operating Activities $290.4K -$570.0K
YoY Change 424.36% -541.96%
INVESTING ACTIVITIES
Capital Expenditures $12.09K $10.00K
YoY Change -121000.0%
Acquisitions
YoY Change
Other Investing Activities -$980.00 -$10.00K
YoY Change -99.56% -119.94%
Cash From Investing Activities -$23.07K -$10.00K
YoY Change -89.75% -119.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.100K 0.000
YoY Change -101.61% -100.0%
NET CHANGE
Cash From Operating Activities 290.4K -570.0K
Cash From Investing Activities -23.07K -10.00K
Cash From Financing Activities -3.100K 0.000
Net Change In Cash 264.2K -580.0K
YoY Change 1029.63% -701.1%
FREE CASH FLOW
Cash From Operating Activities $290.4K -$570.0K
Capital Expenditures $12.09K $10.00K
Free Cash Flow $278.3K -$580.0K
YoY Change 402.44% -549.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Other Receivable After Allowance For Credit Loss Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Accounts Payable Current Related Party Type Extensible Enumeration
AccountsPayableCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Accounts Payable Noncurrent Related Party Type Extensible Enumeration
AccountsPayableNoncurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q3 us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q3 us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
dei Entity Central Index Key
EntityCentralIndexKey
0001586554
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Trading Symbol
TradingSymbol
CBDY
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
617025999
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
617025999
CY2023Q3 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q3 us-gaap Other Receivable After Allowance For Credit Loss Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q3 us-gaap Accounts Payable Current Related Party Type Extensible Enumeration
AccountsPayableCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q3 us-gaap Accounts Payable Noncurrent Related Party Type Extensible Enumeration
AccountsPayableNoncurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q3 us-gaap Inventory Net
InventoryNet
0
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55066
dei Entity Registrant Name
EntityRegistrantName
TARGET GROUP INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3621499
dei Entity Address Address Line1
EntityAddressAddressLine1
20 Hempstead Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Hamilton
dei Entity Address City Or Town
EntityAddressCityOrTown
Ontario
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
L8W 2E7
dei City Area Code
CityAreaCode
1 905
dei Local Phone Number
LocalPhoneNumber
541-3833
dei Security12g Title
Security12gTitle
Common Stock, Par Value $0.0001
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
617025999
CY2023Q3 us-gaap Cash
Cash
445416
CY2022Q4 us-gaap Cash
Cash
223843
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
8506
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
8490
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
128244
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2068
CY2023Q3 us-gaap Inventory Net
InventoryNet
1892739
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
41787
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
41714
CY2023Q3 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
65098
CY2022Q4 cbdy Receivables From Joint Venture Current
ReceivablesFromJointVentureCurrent
630180
CY2023Q3 us-gaap Other Receivables
OtherReceivables
3698
CY2022Q4 us-gaap Other Receivables
OtherReceivables
3692
CY2023Q3 us-gaap Assets Current
AssetsCurrent
2585488
CY2022Q4 us-gaap Assets Current
AssetsCurrent
909987
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5428478
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5554225
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
775577
CY2023Q3 us-gaap Goodwill
Goodwill
263580
CY2022Q4 us-gaap Goodwill
Goodwill
263117
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
49578
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
62728
CY2023Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
5741636
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
6655647
CY2023Q3 us-gaap Assets
Assets
8327124
CY2022Q4 us-gaap Assets
Assets
7565634
CY2023Q3 us-gaap Bank Overdrafts
BankOverdrafts
506
CY2022Q4 us-gaap Bank Overdrafts
BankOverdrafts
506
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2671621
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2296935
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
35254
CY2023Q3 cbdy Related Party Payables Net Current
RelatedPartyPayablesNetCurrent
5595160
cbdy Salary And Wage Nonofficer
SalaryAndWageNonofficer
53083
cbdy Salary And Wage Nonofficer
SalaryAndWageNonofficer
-9775
CY2022Q4 cbdy Related Party Payables Net Current
RelatedPartyPayablesNetCurrent
4468535
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
119151
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
110586
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
480
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
480
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
24159
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
15125
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8411077
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6927421
CY2023Q3 us-gaap Accounts Payable Interest Bearing Noncurrent
AccountsPayableInterestBearingNoncurrent
5539361
CY2022Q4 us-gaap Accounts Payable Interest Bearing Noncurrent
AccountsPayableInterestBearingNoncurrent
5877930
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1230306
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1319619
CY2023Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1770
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
489
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
6771437
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7198038
CY2023Q3 us-gaap Liabilities
Liabilities
15182514
CY2022Q4 us-gaap Liabilities
Liabilities
14125459
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
100
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
100
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
61703
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
61703
CY2023Q3 cbdy Shares To Be Issued Total
SharesToBeIssuedTotal
175392
CY2022Q4 cbdy Shares To Be Issued Total
SharesToBeIssuedTotal
175182
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24985697
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24985697
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30922383
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30783678
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1155899
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-998829
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6855390
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6559825
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8327124
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7565634
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1046227
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1805211
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
454241
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
823502
CY2023Q3 us-gaap Gross Profit
GrossProfit
591986
us-gaap Gross Profit
GrossProfit
981709
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
31779
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
246
us-gaap Professional Fees
ProfessionalFees
47885
us-gaap Professional Fees
ProfessionalFees
18939
CY2023Q3 us-gaap Management Fee Expense
ManagementFeeExpense
78352
CY2022Q3 us-gaap Management Fee Expense
ManagementFeeExpense
19399
us-gaap Management Fee Expense
ManagementFeeExpense
233867
us-gaap Management Fee Expense
ManagementFeeExpense
102915
CY2023Q3 us-gaap Legal Fees
LegalFees
27799
CY2022Q3 us-gaap Legal Fees
LegalFees
41253
us-gaap Legal Fees
LegalFees
231726
us-gaap Legal Fees
LegalFees
213844
CY2023Q3 us-gaap Depreciation
Depreciation
237789
CY2022Q3 us-gaap Depreciation
Depreciation
220390
us-gaap Depreciation
Depreciation
680043
us-gaap Depreciation
Depreciation
673349
CY2023Q3 cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
-119729
CY2022Q3 cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
81976
cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
-137039
cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
115881
CY2023Q3 cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-153041
CY2022Q3 cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-79195
cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-212172
cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-10249
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
648489
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
278507
us-gaap Operating Expenses
OperatingExpenses
1489649
us-gaap Operating Expenses
OperatingExpenses
913190
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-8988
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2040
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-10314
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
18852
cbdy Gain Loss On Settlement Of Liability
GainLossOnSettlementOfLiability
1428185
CY2023Q3 us-gaap Interest Expense
InterestExpense
337675
CY2022Q3 us-gaap Interest Expense
InterestExpense
269106
us-gaap Interest Expense
InterestExpense
1060373
us-gaap Interest Expense
InterestExpense
830167
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
50995
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
130870
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
201
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
172863
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
49346
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
16782
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
747122
CY2023Q3 cbdy Allowance Recovery For Sales Tax Recoverable
AllowanceRecoveryForSalesTaxRecoverable
7868
CY2022Q3 cbdy Allowance Recovery For Sales Tax Recoverable
AllowanceRecoveryForSalesTaxRecoverable
-1756
cbdy Allowance Recovery For Sales Tax Recoverable
AllowanceRecoveryForSalesTaxRecoverable
7868
cbdy Allowance Recovery For Sales Tax Recoverable
AllowanceRecoveryForSalesTaxRecoverable
503
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
93819
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
24152
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
244867
CY2023Q3 cbdy Debt Issuance Costs
DebtIssuanceCosts
12509
CY2022Q3 cbdy Debt Issuance Costs
DebtIssuanceCosts
12855
cbdy Debt Issuance Costs
DebtIssuanceCosts
37266
cbdy Debt Issuance Costs
DebtIssuanceCosts
39098
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-300309
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7642
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
369235
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
314942
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-356812
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-286149
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-138705
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-598248
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-356812
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-286149
us-gaap Net Income Loss
NetIncomeLoss
-138705
us-gaap Net Income Loss
NetIncomeLoss
-598248
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
67911
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-15319
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-157070
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-32664
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-288901
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-301468
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-295775
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-630912
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0006
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0005
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0002
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0010
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-6566588
CY2023Q3 cbdy Shares To Be Issued As Compensation To Intellectual Property Rights Value
SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue
99
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-356812
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
67911
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6855390
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2481289
CY2022Q3 cbdy Shares To Be Issued As Compensation To Intellectual Property Rights Value
SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue
120
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-286149
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-15319
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-2782637
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6559825
cbdy Shares To Be Issued As Compensation To Intellectual Property Rights Value
SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue
210
us-gaap Net Income Loss
NetIncomeLoss
-138705
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-157070
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6855390
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2152112
cbdy Shares To Be Issued As Compensation To Intellectual Property Rights Value
SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue
387
us-gaap Net Income Loss
NetIncomeLoss
-598248
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-32664
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-2782637
us-gaap Profit Loss
ProfitLoss
-138705
us-gaap Profit Loss
ProfitLoss
-598248
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-10314
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
18852
cbdy Gain Loss On Settlement Of Liability
GainLossOnSettlementOfLiability
1428185
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
821
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
408
cbdy Allowance For Sales Tax Recoverable
AllowanceForSalesTaxRecoverable
7868
cbdy Allowance For Sales Tax Recoverable
AllowanceForSalesTaxRecoverable
503
us-gaap Depreciation And Amortization
DepreciationAndAmortization
680043
us-gaap Depreciation And Amortization
DepreciationAndAmortization
673349
us-gaap Operating Lease Expense
OperatingLeaseExpense
178134
us-gaap Operating Lease Expense
OperatingLeaseExpense
198254
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
24152
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
244867
cbdy Debt Issuance Costs
DebtIssuanceCosts
37266
cbdy Debt Issuance Costs
DebtIssuanceCosts
39098
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
126802
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
116135
cbdy Increase Decrease In Sales Tax Recoverable
IncreaseDecreaseInSalesTaxRecoverable
-93043
cbdy Increase Decrease In Sales Tax Recoverable
IncreaseDecreaseInSalesTaxRecoverable
33629
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
390256
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-901898
cbdy Change In Operating Lease Liability Net
ChangeInOperatingLeaseLiabilityNet
241224
cbdy Change In Operating Lease Liability Net
ChangeInOperatingLeaseLiabilityNet
250575
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-879280
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1070205
cbdy Payments For Proceeds From Property Plant And Equipment
PaymentsForProceedsFromPropertyPlantAndEquipment
5363
cbdy Payments For Proceeds From Property Plant And Equipment
PaymentsForProceedsFromPropertyPlantAndEquipment
318
us-gaap Proceeds From Divestiture Of Interest In Joint Venture
ProceedsFromDivestitureOfInterestInJointVenture
440361
us-gaap Proceeds From Divestiture Of Interest In Joint Venture
ProceedsFromDivestitureOfInterestInJointVenture
1240429
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
434998
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1240111
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
668940
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
77980
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
138393
cbdy Payment For Settlement Payable
PaymentForSettlementPayable
10000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
668940
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-70413
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
224658
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
99493
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-3069
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-15549
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
232333
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122151
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
453922
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
206095
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
120
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
120
us-gaap Interest Paid Net
InterestPaidNet
874518
us-gaap Interest Paid Net
InterestPaidNet
2102799
CY2023Q3 us-gaap Area Of Land
AreaOfLand
44000
cbdy Settlement Liabilities Current And Noncurrent
SettlementLiabilitiesCurrentAndNoncurrent
0
CY2021 cbdy Settlement Liabilities Current And Noncurrent
SettlementLiabilitiesCurrentAndNoncurrent
10000
CY2023Q3 cbdy Working Capital Deficit
WorkingCapitalDeficit
5825589
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30922383
CY2017Q3 us-gaap Area Of Land
AreaOfLand
44000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The preparation of the unaudited condensed consolidated interim financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated interim financial statements and the reported amounts of revenues and expenses during the reporting periods. Estimates may include those pertaining to accruals. Actual results could differ from those estimates.</span></p>
CY2022Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0
CY2019Q2 us-gaap Area Of Land
AreaOfLand
44000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1805211
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
cbdy Revenue From Investments In Joint Venture
RevenueFromInvestmentsInJointVenture
791285
cbdy Revenue From Investments In Joint Venture
RevenueFromInvestmentsInJointVenture
3177105
CY2023Q3 us-gaap Inventory Net
InventoryNet
1892739
CY2023Q3 cbdy Allowance On Value Added Tax Recoverable
AllowanceOnValueAddedTaxRecoverable
7829
CY2022Q4 cbdy Allowance On Value Added Tax Recoverable
AllowanceOnValueAddedTaxRecoverable
0
CY2023Q3 cbdy Depreciation Of Joint Venture Consolidated
DepreciationOfJointVentureConsolidated
38489
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8954580
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3526102
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5428478
CY2023Q2 cbdy Asset Acquired Fair Value Of Inventory Joint Venture
AssetAcquiredFairValueOfInventoryJointVenture
1690368
CY2023Q2 cbdy Asset Acquired Fair Value Of Fixed Assets Joint Venture
AssetAcquiredFairValueOfFixedAssetsJointVenture
534816
CY2023Q2 cbdy Asset Acquired Fair Value Joint Venture
AssetAcquiredFairValueJointVenture
2225184
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
1023608
CY2023Q2 cbdy Receivables From Joint Venture Current
ReceivablesFromJointVentureCurrent
706598
CY2023Q2 cbdy Release And Settlement Amount To Come Out Of Joint Venture
ReleaseAndSettlementAmountToComeOutOfJointVenture
776382
CY2023Q2 cbdy Investment In Joint Venture Balance
InvestmentInJointVentureBalance
953824
CY2023Q2 cbdy Gain From Termination Of Joint Venture
GainFromTerminationOfJointVenture
1428185
CY2018Q2 cbdy Business Acquisition Equity Interest Issuable Percentage
BusinessAcquisitionEquityInterestIssuablePercentage
0.4627
CY2022 cbdy Class Of Warrant Or Right Warrants Exercised During Period
ClassOfWarrantOrRightWarrantsExercisedDuringPeriod
0
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3720331
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3988170
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
7708501
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2125856
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5582645
CY2023Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
125623
CY2023Q3 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
67098
CY2023Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
58525
CY2023Q3 cbdy Accrued Interest Converted Into Principal
AccruedInterestConvertedIntoPrincipal
665640
CY2023Q3 cbdy Accrued Interest Converted Into Principal
AccruedInterestConvertedIntoPrincipal
900000
CY2023Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
3886380
CY2023Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2874366
CY2023Q3 us-gaap Line Of Credit
LineOfCredit
3786380
CY2023Q3 us-gaap Line Of Credit
LineOfCredit
2800406
us-gaap Line Of Credit Facility Periodic Payment Interest
LineOfCreditFacilityPeriodicPaymentInterest
740286
us-gaap Line Of Credit Facility Periodic Payment Interest
LineOfCreditFacilityPeriodicPaymentInterest
996347
CY2023Q3 cbdy Line Of Credit Facility Accrued Interest
LineOfCreditFacilityAccruedInterest
693152
CY2023Q3 cbdy Line Of Credit Facility Accrued Interest
LineOfCreditFacilityAccruedInterest
937199
CY2023Q1 cbdy Advance Paid To Related Party
AdvancePaidToRelatedParty
500000.00
CY2023Q1 cbdy Lender Fees
LenderFees
50000
cbdy Number Of Operating Lease Facilities
NumberOfOperatingLeaseFacilities
2
CY2023Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.16
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
80011
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
323245
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
326477
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
329742
CY2023Q3 cbdy Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
1123521
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2182996
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
833539
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1349457
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
119151
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1230306
CY2023Q3 cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
58375
CY2022Q3 cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
65215
cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
178134
cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
198254
CY2023Q3 cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
61354
CY2022Q3 cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
135584
cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
244560
cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
387474
CY2022Q3 cbdy Recoverable Expenses From Jv Co Related To Rent And Utilities
RecoverableExpensesFromJvCoRelatedToRentAndUtilities
282775
cbdy Recoverable Expenses From Jv Co Related To Rent And Utilities
RecoverableExpensesFromJvCoRelatedToRentAndUtilities
285655
cbdy Recoverable Expenses From Jv Co Related To Rent And Utilities
RecoverableExpensesFromJvCoRelatedToRentAndUtilities
701609
CY2023Q3 cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
119729
CY2022Q3 cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
-81976
cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
137039
cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
-115881
us-gaap Interest Expense Debt
InterestExpenseDebt
10
us-gaap Interest Expense Debt
InterestExpenseDebt
27
CY2023Q2 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
138
CY2023Q1 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
160
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.42
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.05
CY2023Q3 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2023Q2 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2023Q1 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q3 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
313
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
15125
cbdy Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
9034
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
24159
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
617025999
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
617025999
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
100
cbdy Schedule Of Shares To Be Issued
ScheduleOfSharesToBeIssued
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:47.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Description</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">80,000 shares of common stock to be issued as compensation to advisers and consultants. These were recorded at fair value of $52,000, based on the market price of the Company’s stock on the date of issue.</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 115,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 73,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">35,000 to be issued as settlement of the amount due for website development services amounting to $247,306. The fair value of the shares on the date of settlement was $21,000, resulting in a gain on settlement amounting to $226,306 during the year ended December 31, 2017.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Private placements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 346,296</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,787</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Consideration for private placements with the fair value based on cash proceeds received. Proper allocation between common stock and additional paid-in capital of the amount received will be completed in the period when the shares are issued.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Settlement of loans of CannaKorp</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 930,240</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 80,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Refer to Note 14 for details.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Agreement with Serious Seeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 234,360</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,767</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">As consideration for intellectual property rights granted by Smit. The fair value is based on the market price of the Company’s stock on the date of issue as per the agreement.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,625,896</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 175,392</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr></table>
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
115000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
73000
CY2023Q3 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2023Q2 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2023Q1 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.300
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.99
CY2022Q4 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2022Q3 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2022Q2 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2022Q1 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.300
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.300
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.300
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.250
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.79
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.79
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.99
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.06
CY2022Q4 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2022Q3 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2022Q2 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2022Q1 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q4 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
176
CY2022Q3 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
288
CY2022Q2 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
306
CY2022Q1 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
430
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10400008
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
53950001
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
489
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
611
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
669
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1769
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1377731
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1862805
CY2023Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
10867

Files In Submission

Name View Source Status
tmb-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
tmb-20230930_cal.xml Edgar Link unprocessable
0001410578-23-002246-index-headers.html Edgar Link pending
0001410578-23-002246-index.html Edgar Link pending
0001410578-23-002246.txt Edgar Link pending
0001410578-23-002246-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20230930.xsd Edgar Link pending
tmb-20230930x10q.htm Edgar Link pending
tmb-20230930xex10d35.htm Edgar Link pending
tmb-20230930xex31d1.htm Edgar Link pending
tmb-20230930xex31d2.htm Edgar Link pending
tmb-20230930xex32d1.htm Edgar Link pending
tmb-20230930_def.xml Edgar Link unprocessable
tmb-20230930_lab.xml Edgar Link unprocessable
tmb-20230930x10q_htm.xml Edgar Link completed